⌕
Tilray Brands · TLRY · Nasdaq
Tenet 45 · Mixed
Compare
$2.35+0.43%At closeTenet 45 · Mixed
$2.35+0.01 (+0.43%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Tilray Brands (TLRY) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is TLRY's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● InvezzNov 17, 2026 · 08:30 ET
Tilray Brands stock has crashed to a record low: is this fallen angel a buy?

Tilray Brands stock extended its sell-off this week, sinking to a record low as concerns about the company intensified. The shares fell to $2.34, leaving them down 74% so far this year, 55% over the past six months, and …

TLRY +0.4% todayRead at source ↗
● The Motley FoolNov 16, 2026 · 16:35 ET
Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?

Tilray has been aggressively pursuing acquisitions in recent years. Its focus has largely been on loading up on craft brewers in the U.S. market.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolNov 10, 2026 · 06:05 ETEARNINGS EXPECTED BY FEB 19
Does Marijuana Rescheduling Really Help Tilray's Stock?

Rescheduling marijuana to a lower level makes the substance easier to research and results in lower tax bills for companies. Tilray, however, is a Canadian producer and won't directly see any benefits from rescheduling.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolNov 9, 2026 · 08:26 ETEARNINGS EXPECTED BY FEB 19
Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?

Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than before.…

TLRY +0.4% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 10:01 ET
Tilray Brands, Inc. (TLRY) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Tilray Brands (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.…

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireNov 2, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth

Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation Yields and Expected Ree…

TLRY +0.4% todayRead at source ↗
● The Motley FoolNov 1, 2026 · 16:15 ETEARNINGS EXPECTED BY FEB 19
Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Tilray Brands has shifted from a marijuana company to a global brand manager across marijuana, beverages, and wellness. The company's fiscal first quarter 2027 earnings highlight just how much the business has changed.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolNov 1, 2026 · 02:00 ETEARNINGS EXPECTED BY FEB 19
Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Tilray reported record quarterly revenue of $257.1 million. Cannabis revenue declined 13% despite strong international growth.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 30, 2026 · 14:59 ETEARNINGS EXPECTED BY FEB 19
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.…

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireOct 29, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Tilray Brands Announces Next Phase of Beverage Transformation

Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to Six Identifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen Margins Transformation Initiativ…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 27, 2026 · 08:46 ET
Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?

Tilray's low valuation may be enticing to investors as its market cap is just $400 million. The business, however, struggles to grow organically on a consistent basis.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 25, 2026 · 07:15 ET
Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.

Tilray started out as a pure-play marijuana company. The company has since decided to shift toward a consumer staples approach, selling branded products beyond pot.…

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireOct 21, 2026 · 07:00 ET
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers

ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), and West Ham…

TLRY +0.4% todayRead at source ↗
● Defense WorldOct 16, 2026 · 03:41 ET
Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why

Tilray Brands, Inc. (TSE: TLRY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$4.61 and last traded at C$4.64, with a volume of 1,317,279 shares. T…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 15, 2026 · 17:54 ET
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its revenue streams.…

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireOct 13, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

CANTANHEDE, Portugal, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (N…

TLRY +0.4% todayRead at source ↗
● Seeking AlphaOct 13, 2026 · 01:17 ETEARNINGS EXPECTED BY FEB 19
BrewDog Acquisition Boosts Tilray's Q1 Performance

Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operations; Cannabis revenue decreased. The company expects its new beer assets along with its international cannabis operation…

TLRY +0.4% todayRead at source ↗
● Seeking AlphaOct 12, 2026 · 16:40 ETEARNINGS EXPECTED BY FEB 19
Tilray Q1: Not Looking Good, Remains A 'Hold'

Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highlighting record sales. TLRY's revenue growth was driven solely by the BrewDog acquisition; core cannabis sales declined 13…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 12, 2026 · 14:25 ETEARNINGS EXPECTED BY FEB 19
3 Huge Red Flags From Tilray's Q1 Earnings Report

Tilray's cash burn continues to be a big problem for investors. The business has been growing through acquisitions, and while that can boost the top line, it can also lead to significantly higher expenses.…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 10, 2026 · 17:18 ET
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA. Tilray Brands has diversified its revenue stream significantly through a large craft bee…

TLRY +0.4% todayRead at source ↗
● The Motley FoolOct 10, 2026 · 14:00 ETEARNINGS EXPECTED BY FEB 19
3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray's financial results have been weak for years. The company operates in an uncertain industry.…

TLRY +0.4% todayRead at source ↗
● MarketBeatOct 9, 2026 · 11:26 ET
Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

Tilray Brands TodayTLRYTilray Brands$3.44 -0.15 (-4.04%) As of 11:26 AM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$3.38▼$20.20Price Target$6.38Add to WatchlistWhen investors h…

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireOct 8, 2026 · 07:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 19
Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution

First-Quarter Results Reinforce Tilray's Progress Converting Global Scale, Disciplined Execution and Category Leadership into Higher Revenue, Expanded Gross Profit and Continued Momentum Record First-Quarter Net Revenue …

TLRY +0.4% todayRead at source ↗
● GlobeNewsWireOct 7, 2026 · 12:00 ET
BrewDog's Winning Streak Rolls on with Gold at the Scottish Beer Awards

Hazy Jane Tropical and Krush Test Dummy take Gold as BrewDog builds on its recent sweep at the 2026 World Beer Awards. ELLON, Scotland, Oct. 07, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of t…

TLRY +0.4% todayRead at source ↗

Expected by Feb 19. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA33−0.4%
DLB4−3.8%
WDAY4−5.8%

Article counts from the last market-wide feed page, across every symbol we track and not just TLRY · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.